Racial and ethnic differences in diabetes mellitus among people with and without psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions

General Hospital Psychiatry

Volumn 33, Issue 2, 2011, Pages 107-115

  Cabassa, Leopoldo J ^a,b   Blanco, Carlos ^a,b   Lopez Castroman, Jorge ^c   Lin, Keng Han ^a   Lui, Shang Min ^a   Lewis Fernández, Roberto ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c 28400 Madrid   (Spain)

Author keywords

Diabetes mellitus; Health disparities; NESARC; Psychiatric disorders

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CULTURAL FACTOR; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HEALTH DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR;

ADULT; COMORBIDITY; DIABETES MELLITUS; EPIDEMIOLOGIC STUDIES; FEMALE; HEALTH STATUS DISPARITIES; HEALTH SURVEYS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; UNITED STATES;

EID: 79955986957     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2010.11.011     Document Type: Article

References (49)

1. National Institute of Diabetes and Digestive and Kidney Disease National Diabetes Information Clearinghouse: national diabetes statistics 2007, Accessed March 30, 2010. http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm.
2. Lanting L.C., Joung I.M., Mackenbach J.P., Lamberts S.W., Bootsma A.H. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care 2005, 28(9):2280-2288.
3. Institute of Medicine Unequal treatment: confronting racial and ethnic disparities in health Care 2003, The National Academies Press, Washington (DC).
4. Centers for Disease Control and Prevention National diabetes fact sheet: general information and national estimates on diabetes in the United States 2007, Accessed March 29, 2010. http://www.cdc.gov/diabetes/pubs/factsheet07.htm.
5. Institute of Medicine Improving quality of health care for mental and substance use conditions: quality chasm series 2006, National Academies Press, Washington (DC).
6. Ciechanowski P.S., Katon W.J., Russo J.E. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000, 160(21):3278-3285.
7. Jackson C.T., Covell N.H., Drake R.E., Essock S.M. Relationship between diabetes and mortality among persons with co-occurring psychotic and substance use disorders. Psychiatr Serv 2007, 58(2):270-272.
8. Musselman D.L., Betan E., Larsen H., Phillips L.S. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003, 54(3):317-329.
9. Lin E.H.B., Rutter C.M., Katon W., et al. Depression and advanced complications of diabetes. Diabetes Care 2010, 33(2):264-269.
10. Grigsby A.B., Anderson R.J., Freedland K.E., et al. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 2002, 53(6):1053-1060.
11. Howard A.A., Arnsten J.H., Gourevitch M.N. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med 2004, 140(3):211-219.
12. Dixon L., Weiden P., Delahanty J., et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000, 26(4):903-912.
13. Banerjea R., Sambamoorthi U., Smelson D., Pogach L.M. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. J Behav Health Serv Res 2008, 35(3):290-303.
14. Frayne S.M., Halanych J.H., Miller D.R., et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med 2005, 165(22):2631-2638.
15. Popkin M.K., Callies A.L., Lentz R.D., Colon E.A., Sutherland D.E. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psychiatry 1988, 45(1):64-68.
16. Frankenburg F.R., Zanarini M.C. Obesity and obesity-related illnesses in borderline patients. J Personal Disord 2006, 20(1):71-80.
17. Albu J.B., Kovera A.J., Allen L., et al. Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women. Am J Clin Nutr 2005, 82(6):1210-1217.
18. Castro F.G., Shaibi G.Q., Boehm-Smith E. Ecodevelopmental contexts for preventing type 2 diabetes in Latino and other racial/ethnic minority populations. J Behav Med 2009, 32(1):89-105.
19. Center for Disease Control and Prevention Differences in prevalence of obesity among Blacks, White and Hispanic adults: United States, 2006-2008. Morb Mortal Wkly Rep 2009, 58(27):740-744.
20. Goran M.I., Bergman R.N., Cruz M.L., Watanabe R. Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 2002, 25(12):2184-2190.
21. Popkin B.M., Duffey K., Gordon-Larsen P. Environmental influences on food choice, physical activity and energy balance. Physiol Behav 2005, 86(5):603-613.
22. Ader M., Garvey W.T., Phillips L.S., et al. Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia. J Psychiatr Res 2008, 42:1076-1085.
23. Lambert B.L., Chou C.H., Chang K.Y., Tafesse E., Carson W. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims. Pharmacoepidemiol Drug Saf 2005, 14(6):417-425.
24. Henderson D.C., Nguyen D.D., Copeland P.M., et al. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry 2005, 66:1116-1121.
25. Stecker T., Fortney J.C., Steffick D.E., et al. The triple threat for chronic disease: obesity, race and depression. Psychosomatics 2006, 47(6):513-518.
26. Grant B.F., Dawson D.A., Hasin D.S. The Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions Alcohol Use Disorder and Associated Disabilities Interview Schedule - DSMIV Version 2004, National Institute on Alcohol Abuse and Alcoholism, Bethesda (MD).
27. Grant B.F., Kaplan K.K., Stinson F.S. Source and accuracy statement: the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions 2007, National Institute on Alcohol Abuse and Alcoholism, Bethesda (MD).
28. Grant B.F., Goldstein R.B., Chou S.P., et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Molecular Psychiatry 2009, 14:1051-1066.
29. Grant B., Kaplan K. Source and accuracy statement for the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) 2005, National Institute on Alcohol Abuse and Alcoholism, Rockville (MD).
30. Ruan W.J., Goldstein R.B., Chou S.P., et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend 2008, 92(1-3):27-36.
31. Grant B.F., Dawson D.A., Stinson F.S., et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend 2003, 71:7-16.
32. Grant B.F., Harford T.C., Dawson D.A., et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend 1995, 39:7-44.
33. Hasin D., Carpenter K.M., McCloud S., et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend 1997, 44:133-141.
34. Canino G., Bravo M., Ramirez R., et al. The Spanish The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with a clinical diagnoses in a Hispanic population. J Stud Alcohol 1990, 60:790-799.
35. Research Triangle Institute Software for survey data analysis (SUDAAN) version 9.0.3. Research Triangle Park (NC) 2007.
36. Venkat Narayan K.M., Aviles-Santa L., Oza-Frank R., et al. Report of a National Heart, Lung, and Blood Institute Workshop: heterogeneity in cardiometabolic risk Asian Americans in the U. S.: opportunities for research. J Am Coll Cardiol 2010, 55:966-973.
37. Oza-Frank R., Ali M.K., Vaccarino V., Venkat Narayan K.M. Asian Americans: diabetes prevalence across U.S. and World health organization weight classifications. Diabetes Care 2009, 32(9):1644-1646.
38. Bitton A., Zaslavsky A.M., Ayanian J.Z. Health risks, chronic diseases, and access to care among U.S. Pacific Islanders. J Gen Intern Med 2010, 25(5):435-440.
39. American Diabetes Association, et al. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry 2004, 65(2):267-272.
40. Marder S.R., Essock S.M., Miller A.L., et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004, 161(8):1334-1349.
41. Druss B.G., Rohrbaugh R.M., Levinson C.M., Rosenheck R.A. Integrated medical care for patients with serious psychiatric illness: a randomized trial. Arch Gen Psychiatry 2001, 58(9):861-868.
42. Kilbourne A.M., Post E.P., Nossek A., Drill L., Cooley S., Bauer M.S. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. Psychiatr Serv 2008, 59(7):760-768.
43. Katon W.J., Von Korff M., Lin E.H., et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004, 61(10):1042-1049.
44. Brar J.S., Ganguli R., Pandina G., Turkoz I., Berry S., Mahmoud R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2005, 66(2):205-212.
45. McKibbin C.L., Patterson T.L., Norman G., et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006, 86(1-3):36-44.
46. Druss B.G., von Esenwein S.A., Compton M.T., Rask K.J., Zhao L., Parker R.M. A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. Am J Psychiatry 2010, 167(2):151-159.
47. Lin E.H., Korff M.V., Alonso J., et al. Mental disorders among persons with diabetes - results from the World Mental Health Surveys. J Psychosom Res 2008, 65(6):571-580.
48. Center for Disease Control and Prevention Prevalence of diabetes among Hispanics: selected areas. Morb Mortal Wkly Rep 2004, 53(40):941-944.
49. Alegria M., Mulvaney-Day N., Torres M., Polo A., Cao Z., Canino G. Prevalence of psychiatric disorders across Latino subgroups in the United States. Am J Public Health 2007, 97(1):68-75.